News and Publications

ImmuneOncia “First anti-PD-L1 immunotherapy drug in Korea, clinical phase next year”

ImmuneOncia “First anti-PD-L1 immunotherapy drug in Korea, clinical phase next year” Yuhan-Sorrento joint venture company, fastest development in Korea.. “Later to expedite the development of ‘macrophage-activating anti-CD47 antibody’” “We plan to apply anti-PD-L1 ‘IMC-001’ antibody [...]

By | 2017/09/04|Categories: News and Publications|0 Comments

Yuhan Corporation And Sorrento Therapeutics Form Joint Venture Company – ImmuneOncia

https://www.fiercebiotech.com/biotech/yuhan-corporation-and-sorrento-therapeutics-form-joint-venture-company-immuneoncia

By | 2017/02/21|Categories: News and Publications|0 Comments